Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Aug 11, 2022 · 10-Q · 42 days after period end · 0001654954-22-011073
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$2.86M | -$1.72M | -$2.15M | $1.76M |
| EPS Diluted | — | -$0.10 | -$0.23 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 11, 2022 · 42 d after period end
